ArticlePloS one2012

Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease.

Mario A Cabrera-Salazar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.